Don’t Abolish Success: Why Britain Was Wrong to Scrap Local Enterprise Partnerships
For fourteen years I have had the privilege of supporting Hertfordshire’s Local Enterprise Partnership (LEP), working alongside outstanding business leaders, local authorities, universities, colleges and government departments to drive economic growth across one of the UK’s most successful counties. Today, as Chair of Hertfordshire Futures, that work continues through its integration into Hertfordshire County Council. […]
Democracy Demands More Than a Tick in a Box
The United Kingdom rightly prides itself on being one of the world’s oldest democracies. Universal suffrage was not gifted lightly; it was earned over generations through sacrifice, reform and the belief that every citizen should have a voice in shaping the nation’s future. Yet democracy is not standing still. Falling electoral turnout, declining trust in […]
Cambridge Discovers. Stevenage Cures. Britain Needs Both.
GSK’s announcement of a £400 million investment in a new global research and development centre on the Cambridge Biomedical Campus is excellent news for the United Kingdom. It reinforces Cambridge’s position as one of the world’s foremost centres for biomedical research and underlines the confidence that major international companies continue to place in British science. […]
The Future of Medicine May Not Be Another Pill
GSK’s decision to invest £400 million in a flagship research centre on the Cambridge Biomedical Campus confirms Britain’s position as one of the world’s leading centres for pharmaceutical research. Cambridge deserves that recognition. Its universities, hospitals and research institutes have helped shape modern medicine for generations. Yet the announcement also exposes a far more important […]
Britain’s Next Medical Revolution Will Not Be Built on Pharmaceuticals Alone
Cambridge will continue to discover tomorrow’s medicines. Hertfordshire could help deliver tomorrow’s cures. Britain’s Life Sciences Strategy must recognise the difference. GSK’s announcement of a £400 million investment in a new global Research and Development centre on the Cambridge Biomedical Campus is welcome news. It reinforces Britain’s standing as a world leader in pharmaceutical […]